NCT02973724View on ClinicalTrials.gov

EC95 of Remifentanil for Preventing Cough

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Drug Usage
Interventions
DRUG

Remifentanil

The concentration of remifentanil was determined by biased-coin up and down design, starting from 1.0 ng/ml (0.4 ng/ml as a step size)

DRUG

Propofol anesthesia

Anesthesia was induced with propofol target-controlled infusion at an effect-site concentration of 5.0 μg/ml.

Trial Locations (1)

443-721

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02973724 - EC95 of Remifentanil for Preventing Cough | Biotech Hunter | Biotech Hunter